Two Sigma Securities »

Aligos Therapeutics shares owned by Two Sigma Securities

Quarter-by-quarter ownership of Aligos Therapeutics (ALGS) shares owned by Two Sigma Securities from 13F filings

Historical chart of Two Sigma Securities investment in Aligos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aligos Therapeutics held by Two Sigma Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aligos Therapeutics by Two Sigma Securities

Quarter filed Position value Share count Share price at filing
2023-12-31 $9.8k 15k 0.66

More positions owned by Two Sigma Securities

NVIDIA Corporation Call Option (NVDA)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Chevron Corporation (CVX)
Advanced Micro Devices Call Option (AMD)
Netflix Call Option (NFLX)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Broadcom (AVGO)
Super Micro Computer Call Option (SMCI)
Eli Lilly & Co. Call Option (LLY)
Lockheed Martin Corporation Call Option (LMT)

View all positions for Two Sigma Securities

Top funds holding Aligos Therapeutics

Armistice Capital
EcoR1 Capital
Alyeska Investment Group
Vivo Capital
Altitude Crest Partners
Adage Capital Partners GP
Versant Venture Management
Baker Bros. Advisors
Hillhouse Capital Advisors
Tang Capital Management
Opaleye Management
Newtyn Management
Bank of America Corporation
Vanguard Group
Acadian Asset Management

View all funds holding Aligos Therapeutics